Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions

Clinical trial NCT06201559 · COMPLETED

Trial details

NCT number: NCT06201559
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intestinal Diseases

Start date: 2023-08-21
Primary completion: 2023-09-12
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.